Read More
Dapagliflozin improves glucose outcomes in type 1 diabetes
(HealthDay)—In patients with type 1 diabetes, treatment with dapagliflozin for 24 weeks improves time in range, mean glucose, and glycemic variability, according to a study published online April 9 in Diabetes Care.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Read More
Subscribe to:
Post Comments (Atom)
0 Response to "Dapagliflozin improves glucose outcomes in type 1 diabetes"
Post a Comment